Subscribe To
TMO / Healthy Dividends: Thermo Fisher's Growth Fuels Capital Deployments
TMO News
By Market Watch
October 25, 2023
Thermo Fisher's stock on track for lowest close in more than three years after revenue miss and lowered guidance
Thermo Fisher Scientific Inc.'s stock TMO, -7.80% fell about 9% Wednesday to put it on track for its lowest close in more than three years, after the more_horizontal
By Proactive Investors
October 25, 2023
Thermo Fisher lowers profit and sales outlook on soft demand, rising costs
Thermo Fisher Scientific (NYSE:TMO) issued a forecast for full-year profit and sales that falls below Wall Street expectations on lower-than-expected more_horizontal
By Zacks Investment Research
October 25, 2023
Thermo Fisher Scientific (TMO) Beats Q3 Earnings and Revenue Estimates
Thermo Fisher Scientific (TMO) came out with quarterly earnings of $5.69 per share, beating the Zacks Consensus Estimate of $5.58 per share. This comp more_horizontal
By Barrons
October 25, 2023
Thermo Fisher Stock Slumps After Sales Miss and Outlook Is Slashed Again
The leading maker of scientific equipment slashes its guidance for the second consecutive quarter, citing a challenging macro environment. more_horizontal
By Reuters
October 25, 2023
Thermo Fisher cuts annual profit forecast on weak biotech demand
Medical equipment maker Thermo Fisher Scientific on Wednesday cut its annual profit forecast for the second straight quarter, hurt by lower-than-expec more_horizontal
By Proactive Investors
October 17, 2023
Olink Holding stock soars on acquisition by Thermo Fisher Scientific
Olink Holding AB shares surged 66% to $24.87 in late-morning trading on Tuesday after the provider of next-generation proteomics solutions announced t more_horizontal
By Barrons
October 17, 2023
Thermo Fisher to Buy Sweden's Olink for $3.1 Billion
Thermo Fisher will acquire proteomics company Olink for $26 per American depositary share in cash. more_horizontal
By Market Watch
October 17, 2023
Thermo Fisher's stock slips after deal to buy Sweden's Olink for a 74% premium
Thermo Fisher Scientific Inc. TMO, +1.18% announced Tuesday an agreement to buy Sweden-based proteomics company Olink Holding AB OLK, +0.47% in a deal more_horizontal